# The Metformin in Coronary Artery Bypass Graft (CABG) (MetCAB) Trial

> **NCT01438723** · PHASE4 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 100 (actual)

## Conditions studied

- Cardiovascular Disease
- Ischemic Heart Disease

## Interventions

- **DRUG:** Metformin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01438723
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2014-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01438723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01438723, "The Metformin in Coronary Artery Bypass Graft (CABG) (MetCAB) Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01438723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*